Archive for the ‘Dermatology’ Category

Diabetes trial stops treatment arm in wake of death risk

Sunday, February 17th, 2008

Washington — The halting on Feb. 6 of an arm of the large type 2 diabetes trial, ACCORD, sent shock waves through the medical community. The lower-the-better conventional wisdom for blood glucose levels was questioned when it was found that those getting the most intensive glucose-lowering treatments were more likely to die.

But treatment strategies — keeping blood glucose, blood pressure and cholesterol levels in check — are likely to remain unchanged for the vast majority of the millions of people with type 2 diabetes. What might change is an overly aggressive pursuit of low blood glucose levels in patients with or at risk for cardiovascular disease.

(more…)

Kinds Of Arthritis

Wednesday, February 6th, 2008

If you’re new here, you may want to subscribe to my RSS feed.Thanks for visiting!

www.arthritis.org

Arthritis medicine|arthritic remedy
Arthritis medicine for the relief of pain from Arthritis, Backache ,Strains and Sprains Supplements, Vitamins and More!

A Herbal Healer Academy - natural medicine, herbs, vitamins
Cancer, arthritis, heart problems, diabetes, depression, Lupus, GWS, Fibromyalgia, CFS, and many other conditions have been helped, and in some cases completely healed by the

(more…)

Healthy Alternatives To Drinking Alcohol

Wednesday, February 6th, 2008

If you’re new here, you may want to subscribe to my RSS feed.Thanks for visiting!

aim to evaluate the effect of combining conventional and alternative care on health COLORADO HEALTH INSURANCE: DENTAL CARE: DEPRESSION SYMPTOMS TREATMENT: DIABETES SYMPTOMS AND CARE

Affordable Health Insurance
State Directory of Health Insurance, Dental, Vision and Alternative Care Plans For More Information About NASRO and to Speak to a NASRO Staff person Call

(more…)

Eli Lilly to withdraw advice leaflet

Friday, December 21st, 2007


The Medicines and Healthcare products Regulatory Agency (MHRA) has forced Eli Lilly to withdraw an advice leaflet. The leaflet, providing doctors with advice on treatments for mental health, was written on behalf of Diabetes UK and carried the logo of the charity, reports the Financial Times.

However, Eli Lilly admitted that it omitted to include that it had sponsored the leaflet, calling the mistake an oversight. The firm was also criticised for not making the risk of schizophrenia medicines clear, including its own drug Zyprexa (olanzapine), to people suffering from hyperglycaemia and diabetes. The MHRA has called for Eli Lilly to withdraw the information, originally distributed in 2003, although it was removed in May last year by the firm.

(more…)

Boehringer Ingelheim and Eli Lilly change Yentreve AriClaim deal

Friday, December 21st, 2007


Eli Lilly is to buy back worldwide marketing rights for Yentreve/AriClaim (duloxetine hydrochloride) from Boehringer Ingelheim. As a stress urinary incontinence (SUI) treatment, along with future related urinary incontinence indications, the drug will continue to be marketed outside the US by Lilly but other treatments using duloxetine will remain under both firms.

Lilly president and chief operating officer John Lechleiter said: “Based on our collective experiences to date in the marketplace, both companies believe that the Yentreve/AriClaim opportunity is best suited and can be best commercialised in markets outside the US with the support of one company. “This is about ‘right sizing’ our investments to address our greatest opportunities and the greatest patient needs.” Dr Alessandro Banchi, Boehringer Ingelheim chairman of the board of managing directors, added: “There has been an excellent spirit of collaboration in our alliance with Lilly.
(more…)

Estrogen in young postmenopausal women linked to less arterial plaque

Friday, December 21st, 2007

New results from a substudy of the Women’s Health Initiative (WHI) Estrogen-Alone Trial show that younger postmenopausal women who take estrogen-alone hormone therapy have significantly less buildup of calcium plaque in their arteries compared to their peers who did not take hormone therapy. Coronary artery calcium is considered a marker for future risk of coronary artery disease.

Results of the WHI Coronary Artery Calcium Study are published in the June 21, 2007, issue of the New England Journal of Medicine. The WHI is sponsored by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.

(more…)

Indoor Tanning Patterns Help Doctor’s Target Prevention

Wednesday, December 19th, 2007

(Ivanhoe Newswire) — Evidence that indoor tanning poses a serious skin cancer risk is rising. A new study helps doctors identify who’s doing the tanning and why so they can better target prevention messages. The study revealed that when it comes to indoor tanning, one size does not fit all.

Joel Hillhouse, Ph.D., at the East Tennessee State University, Johnson City and his colleagues studied the indoor tanning behaviors of 168 young women between January 2006 and April 2006. The average age of the participants was 20 and they all attended a southeastern university. They were all asked to fill out questionnaires to determine behavioral patterns, intentions, attitudes and perceptions abut indoor tanning. It also measured indoor tanning norms, perceived subjective norms and indoor tanning dependence and predictors.

(more…)

Allergy Basics FAQ Nose and Eye Allergies Skin (Allergies Immune System)

Sunday, December 16th, 2007

If you’re new here, you may want to subscribe to my RSS feed.Thanks for visiting!

Allergy Basics FAQ Nose and Eye Allergies Skin Allergies Asthma and Lung … Development of allergies in children. Peanut-free diet. Eczema/Atopic dermatitis …

Something to Blush About

Tuesday, December 11th, 2007

(Ivanhoe Newswire) — The 14 million Americans suffering from rosacea — a skin condition effecting the middle third of the face causing persistent redness in the cheeks and nose — will tell you it’s nothing to “blush off.” Little has been known about the cause of the disease, but new research reveals a little mite may be behind the blushing disease.

Demodex folliculorum, microscopic mites, are normal inhabitants of human skin. Previous studies have established that the mites occur in great numbers on the faces of people with rosacea, but doctors weren’t sure whether they played a role in the development of the disease.

(more…)

Can Speeding up Cancer Cells Actually Stop Them?

Thursday, November 29th, 2007

By Lindsay Braun, Ivanhoe Men’s health Correspondent

ORLANDO, Fla. (Ivanhoe Newswire) — The key to stopping cancer may lie in one drug’s ability to first speed it up. By accelerating the activity of a cancer-promoting gene, it may be possible to send cancer cells into overdrive until they self-destruct.

Recent research reveals an FDA approved drug called bortezomib is able to selectively kill cancer cells by promoting an acceleration oncogene called c-MYC. By creating a heightened release of c-MYC, a reaction occurs in which a cell-killing protein called NOXA is released.

(more…)